T1	Participants 21 60	severe persistent depressions in women.
T2	Participants 154 265	severely depressed, inpatient women who had failed to respond to various conventional treatments of depression.
T3	Participants 352 404	23 premenopausal and postmenopausal inpatient women.
T4	Participants 459 479	17 similar patients.
T5	Participants 861 901	women receiving high doses of estrogens.
